# A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects

> **NCT04297124** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** CC-90009
- **RADIATION:** [14C]

## Key facts

- **NCT ID:** NCT04297124
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-11
- **Primary completion:** 2021-06-04
- **Final completion:** 2021-06-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04297124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04297124, "A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04297124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*